Short interest in BridgeBio Oncology Therapeutics Inc (NASDAQ:BBOT) increased during the last reporting period, rising from 3.24M to 3.32M. This put 11.66% of the company's publicly available shares short.

Based on the recent average volume of 547.98K shares traded per day, it would take 6.06 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.